The market size of the Surgical Drapes Market was around US$ 1.4 Billion in 2023, and now it is expected to grow with a compound annual growth rate (CAGR) of 4.2% for the period of 2023 to 2033.
The surgical drapes market has been driven in recent years by an increase in the number of surgical procedures and increased awareness of the spread of various illnesses. The market is expected to account for an absolute dollar opportunity of nearly US$ 728.3 Million from 2023 to 2033.
Attribute | Details |
---|---|
Global Surgical Drapes Market (2023) | US$ 1.4 Billion |
Surgical Drapes Market (2033) | US$ 2.1 Billion |
Market CAGR (2023 to 2033) | 4.2% |
USA Surgical Drapes Market CAGR (2023 to 2033) | 4% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Surgical Drapes Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at a CAGR of 3.6%. The market is projected to grow at a CAGR of 4.2% over the coming ten years.
Increasing demand for patient and healthcare worker protection, as well as an increase in the occurrence of the surgical site and hospital-acquired infections, are fueling market expansion. Operating drapes act as a physical barrier, preventing contamination of the surgical field. Surgical drapes will be in high demand as the number of procedures increases.
In 2018, 17.7 million cosmetic operations and minimally invasive treatments were conducted in the United States, according to the American Society of Plastic Surgeons (ASPS). Around 70 million surgical procedures are performed in Europe each year, according to Molnlycke Health Care AB, with an annual growth rate of 3% to 4%.
In 2018, at least 1.16 million caesarean sections were performed in the EU-27, according to Eurostat data. As a result, market growth is likely to be aided by an increase in surgical procedures performed throughout the forecast period.
HAIs are a leading cause for concern for both patients and doctors around the world. The demand for surgical drapes will be increased further by an increase in hospitalizations and HAIs globally. CDC estimates that roughly one out of 31 hospitalized patients will contract a healthcare-associated infection annually.
According to NHSN Surgical Site Infection (SSI) Surveillance statistics, 157,500 SSI infections are expected to occur annually in the United States. With an estimated annual cost of US$ 3.3 billion and 1 million additional hospital days, SSI is the costliest HAI type. They are also a leading cause of morbidity, prolonged hospitalization, unplanned readmissions following surgery, and mortality. As a result, the market expansion is likely to be fueled by the rising prevalence of HAIs and SSIs worldwide.
An increase in the occurrence of chronic diseases around the world is another key factor driving the market forward. According to the American Heart Association, by 2035, more than 130 million people, or 45.1% of the adult population in the United States, could be suffering from some type of CVD. According to the Centers for Disease Control and Prevention, around 655,000 Americans die each year from heart disease, accounting for one out of every four deaths.
According to the CDC, 6 out of 10 persons in the United States suffer from a chronic disease, with 4 out of 10 having two or more chronic conditions. As a result of the rising patient pool, more surgeries and hospitalizations are performed, resulting in a higher demand for surgical drapes.
During the predicted period, the surgical drapes market in North America is expected to increase significantly. The well-developed infrastructure, rising surgical procedures, and an increase in surgical site infections are all contributing to market expansion.
According to CMS.gov, healthcare spending in the United States climbed by 4.6% in 2019, reaching US$ 3.8 trillion per person, accounting for 17.7% of the country's GDP.
According to the Journal of Infectious Disease Advisor, around 27 million surgical operations are conducted in the USA each year, with up to 5% of these procedures resulting in surgical site infections. In addition, rising healthcare costs are a driving force for market expansion.
The China surgical drapes market grew at a CAGR of 3.8% from 2018 to 2022 and is expected to grow with a CAGR of 5.8% during the forecast period. The market continues to grow since the number of medical procedures keeps rising and the population keeps on growing. Expanded technological advances in the healthcare sector and increased research and development activities are forecast to provide newly promising opportunities in the future for healthcare services.
Medical tourism's booming growth in China has resulted in increasing demand for surgical drapes. The market in China is anticipated to have an absolute dollar growth of US$ 106.9 Million from 2023 to 2033.
The United States surgical drapes market is expected to grow to be worth US$ 758.4 Million by 2033, with an absolute dollar growth of US$ 245.2 Million from 2033 to 2033. The market in the United States has grown at a CAGR of 4.3% from 2018 to 2022 and is expected to grow at a CAGR of 4% from 2023 to 2033.
The market in the United Kingdom is expected to grow to be worth US$ 95.9 Million by 2033, with an absolute dollar growth of US$ 30.2 Million from 2023 to 2033. The market in the United Kingdom grew at a CAGR of 2.4% from 2018 to 2022 and is expected to grow at a CAGR of 3.8% from 2023 to 2033.
Japan's surgical drapes market is expected to grow to be worth US$ 93.3 Million by 2033, with an absolute dollar growth of US$ 39.3 Million. The market in the country grew at a CAGR of 3.5% from 2018 to 2022 and is expected to grow at a CAGR of 5.7% from 2023 to 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over the projected period, the market for disposable surgical drapes is expected to grow at a CAGR of 4.8%. Disposable drapes are usually constructed of materials that are non-woven and thrown away after each surgery.
It has several advantages, including low cost, decreased manufacturing expenses, low weight, and easy recycling. Disposable surgical drapes are also more resistant to liquids, abrasion, and tearing than reusable surgical drapes. As a result of the aforementioned benefits of non-woven cloth, disposable surgical drapes are in high demand.
In 2020, the hospital segment accounted for more than 40% of the total revenue. Hospitals are the primary consumers of surgical drapes since they perform the bulk of surgeries globally. Furthermore, as the occurrence of SSI rises, surgical drapes grew significantly in demand in hospitals.
The prevalence of SSI is around 24.6%, according to a report published in Bio Med Central (BMC), with 10% developing deep site SSI, 9.2% developing organ spacing SSI, and 5.2% developing surface space SSI. Furthermore, individuals who had undergone orthopaedic and abdominal procedures exhibited a significant frequency of the condition.
The key players in the global Surgical Drapes market are 3M, Steris, Cardinal Health, Paul Hartmann AG, and Mölnlycke Health Care.
The market boosted at a CAGR of 3.6% from 2018 to 2022.
Through 2033, the market is to develop at a CAGR of 4.2%.
By 2033, the market is to have expanded to US$ 2.1 Billion.
In 2023, the market is anticipated to reach a worth of US$ 1.4 Billion.
The market in China is expected to thrive at a CAGR of 5.8%.
From 2023 to 2033, the market in the United Kingdom is poised to develop at a CAGR of 3.8%.
1. Executive Summary | Surgical Drapes Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Patch Management Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Patch Management Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Analysis, 2018 to 2022 6.2. Current and Future Market Projections, 2023 to 2033 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Type, 2018 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2023 to 2033 8.3.1. Reusable 8.3.2. Disposable 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Risk Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Risk Type, 2018 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Risk Type, 2023 to 2033 9.3.1. Minimal (AAMI Level 1) 9.3.2. Low (AAMI Level 2) 9.3.3. Moderate (AAMI Level 3) 9.3.4. High (AAMI Level 4) 9.4. Market Attractiveness Analysis By Risk Type 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End-Use, 2018 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-Use, 2023 to 2033 10.3.1. Hospitals 10.3.2. Clinics 10.3.3. Ambulatory Surgical Centers 10.3.4. Other End-uses 10.4. Market Attractiveness Analysis By End-Use 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022 11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 12.4.1. By Country 12.4.1.1. USA 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Type 12.4.3. By End-Use 12.4.4. By Risk Type 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Type 12.5.3. By End-Use 12.5.4. By Risk Type 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Type 13.4.3. By End-Use 13.4.4. By Risk Type 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Type 13.5.3. By End-Use 13.5.4. By Risk Type 14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United Kingdom 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Type 14.4.3. By End-Use 14.4.4. By Risk Type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Type 14.5.3. By End-Use 14.5.4. By Risk Type 15. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Type 15.4.3. By End-Use 15.4.4. By Risk Type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By End-Use 15.5.4. By Risk Type 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Type 16.4.3. By End-Use 16.4.4. By Risk Type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Type 16.5.3. By End-Use 16.5.4. By Risk Type 17. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.2.2.1. By Type 17.2.2.2. By End-Use 17.2.2.3. By Risk Type 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.3.2.1. By Type 17.3.2.2. By End-Use 17.3.2.3. By Risk Type 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.4.2.1. By Type 17.4.2.2. By End-Use 17.4.2.3. By Risk Type 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.5.2.1. By Type 17.5.2.2. By End-Use 17.5.2.3. By Risk Type 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.6.2.1. By Type 17.6.2.2. By End-Use 17.6.2.3. By Risk Type 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.7.2.1. By Type 17.7.2.2. By End-Use 17.7.2.3. By Risk Type 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.8.2.1. By Type 17.8.2.2. By End-Use 17.8.2.3. By Risk Type 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.9.2.1. By Type 17.9.2.2. By End-Use 17.9.2.3. By Risk Type 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.10.2.1. By Type 17.10.2.2. By End-Use 17.10.2.3. By Risk Type 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.11.2.1. By Type 17.11.2.2. By End-Use 17.11.2.3. By Risk Type 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.12.2.1. By Type 17.12.2.2. By End-Use 17.12.2.3. By Risk Type 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.13.2.1. By Type 17.13.2.2. By End-Use 17.13.2.3. By Risk Type 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.14.2.1. By Type 17.14.2.2. By End-Use 17.14.2.3. By Risk Type 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.15.2.1. By Type 17.15.2.2. By End-Use 17.15.2.3. By Risk Type 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.16.2.1. By Type 17.16.2.2. By End-Use 17.16.2.3. By Risk Type 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033 17.17.2.1. By Type 17.17.2.2. By End-Use 17.17.2.3. By Risk Type 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. 3M 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Cardinal Health 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Mölnlycke Health Care 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Steris 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Paul Hartmann AG 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. Standard Textile Co. 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. Medline Industries, Inc. 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. Priontex 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. OneMed 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. Medic 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports